The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia

By sjmartinez • February 18, 2024

Sauve K, Watson A, Oh JT, Swift S, Vila-Farres X, Abdelhady W, Xiong YQ, LeHoux D, Woodnutt G, Bayer AS, Schuch R. The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia. J Infect Dis. 2024 Feb 15:jiae027. doi: 10.1093/infdis/jiae027. Epub ahead of print. PMID: 38366561.

Tags: ESKAPE pathogens, Harbor UCLA, Infectious Diseases, Lysin, multidrug-resistance, pneumonia, pseudomonas aeruginosa, Publications, synergy

Family History of Premature Atherosclerotic Cardiovascular Disease and Lipoprotein(a) Levels: A Multi Cohort Analysis

Razavi AC, Bhatia HS, Dardari ZA, Mehta A, Nasir K, Blankstein R, Isiadinso I, Quyyumi AA, Vaccarino V, Fialkow JA, Khoury MJ, Coronado F, Budoff[...]

Trends in Opioid Prescriptions and Short-term Mortality Outcomes for Patients With Chronic Kidney Disease and Chronic Pain

Surbhi S, Mallisetty Y, Shrestha P, Sumida K, Thomas F, Kalantar-Zadeh K, Kovesdy CP. Trends in Opioid Prescriptions and Short-term Mortality Outcomes for Patients With[...]

Interstitial Lung Abnormalities, Coronary Heart Disease, and Mortality

Cutting CC, Rose JA, Tukpah AC, Wada N, Nishino M, Kalra S, Moll MR, Cho MH, Silverman EK, Kinney GL, Rossiter HB, Bjarnadottir H, Gudmundsdottir[...]